EP2364137
Lyfjasviflausn
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.12.2009EP published:
29.3.2017EP application number:
09768284.3
EP translation filed:
12.6.2017Grant published:
15.7.2017EPO information:
European Patent Register
Max expiry date:
2.12.2029Expiry date:
2.12.2018
Title:
PHARMACEUTICAL SUSPENSION
Timeline
Today
3.12.2009EP application
29.3.2017EP Publication
12.6.2017Translation submitted
15.7.2017Registration published
2.12.2018Expires
Owner
Name:
NOVARTIS AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
KABRA, Bhagwati P.Address:
EulessTexas, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
120081 PDate:
5.12.2008Country:
US
Classification
Categories:
A61K 9/00, A61K 9/10, A61K 47/10
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 28.11.2017
Expires: 2.12.2018
Payer: Árnason Faktor